Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...

The Truveta collaboration will extend Regeneron Genetics Center’s ® (RGC TM) world-leading DNA sequence-linked healthcare database ... to scale our genomics initiatives, we seek more targets ...

Illumina and Regeneron ... improving the health of our families and communities, and lowering the cost of care.” “Discoveries from smaller datasets before today’s AI have led to important ...

DNA sequencing company Illumina and biotech Regeneron have invested in electronic health record data company ... The new Truveta Genome Project initiative aims to generate genetic data on tens ...

On Tuesday, 20 May 2025, Regeneron Pharmaceuticals (NASDAQ:REGN) presented at the RBC Capital Markets Global Healthcare Conference ... Factor XI Program: This initiative aims to develop a safer ...

Disclaimer: This is an AI-generated summary ... or copay assistance for Regeneron’s Products from third-party payors and other third parties, including private payor healthcare and insurance ...

Drugmakers, including Regeneron, have committed to additional investments to boost production in the U.S. amid concerns about healthcare funding cuts and mass layoffs at the FDA. "Obviously ...

The Truveta collaboration will extend Regeneron ... "Population scale omics initiatives like this hold incredible promise to accelerate new discoveries, improve human health, and advance ...